Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Fergie, six-time Grammy Award winner and Avon spokesperson, was a special guest at the eighth annual Los Angeles-area Avon Walk for Breast Cancer in Santa Barbara, CA, on September 11-12. The Avon Walk raised more than $6.4 million to advance access to care and breast cancer research, and attracted more than 2,800 participants from 45 states and Canada, including 322 breast cancer survivors.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/avon/42977/
Fergie, eight-time Grammy Award winner and global ambassador for the Avon Foundation for Women, was a special guest at the tenth annual Southern California Avon Walk for Breast Cancer in Santa Barbara, CA, on September 22-23. The Avon Walk Santa Barbara, the seventh of nine Avon Walks this year, raised more than $4.7 million to advance access to care and breast cancer research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58224-fergie-joins-thousands-at-avon-walk-for-breast-cancer-santa-barbara
The American Society for Aesthetic Plastic Surgery (ASAPS), is hosting a panel discussion today on the fast-evolving practice of fat grafting, and how surgeons are discovering best practices to produce the most natural looking results. Physician members of ASAPS concur that less is more when it comes to utilizing a patient’s own fat to enhance certain anatomical regions including the breast and buttocks. Further, they agree that fat grafting is proving to be a novel technique for body sculpting previously neglected areas including women’s and men’s shoulders, pectorals, legs and stomachs to create definition.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310752-asaps-plastic-surgery-fat-grafting/
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
In an effort to support the health and wellness of its guests nationwide, Dickey’s Barbecue Pit has announced that all meats sold in every location will contain “No B.S.” (Bad Stuff) by sourcing only responsibly raised, quality meats. Starting August 15, all chicken sold will now be raised without antibiotics. This breakthrough in sustainability not only comprises the brand’s traditional slow smoked chicken breast, but also will include whole smoked chickens and chicken nuggets served in kids’ meals at select stores. To learn more, click here.
The chicken is 100% vegetarian fed and humanely raised. It is also completely hormone-free and cage-free, ensuring that Dickey’s guests are served only the highest quality poultry with no additives. This announcement accompanies other advances in sustainability by the barbecue brand including humanely handled and sustainably raised brisket as well as locally-made sausage with no nitrates, nitrites* or artificial coloring or flavors. Additionally, all of Dickey’s pork products are free from added hormones**, nitrates, nitrites* and artificial coloring and flavors.
To view the multimedia release go to:
http://www.multivu.com/players/English/7717951-dickeys-barbecue-pit-no-bad-stuff-initiative/
Producido para NVidia, Oreck, Energizer y Lee --
Las grandes empresas están ayudando a encontrar una cura a través de donaciones, la venta de productos de color rosado y la creación de una technologia revolucionaria de escaneo del mama . Aquí están algunas maneras que usted puede ayudar.
Board certified plastic surgeon in Los Angeles Dr. Geoffrey Keyes on Good Morning America discusses the candidates for plastic surgery. http://www.keycare.com or http://www.lookingyourbest.com
Medela today announced the U.S. launch of Calma, a product designed exclusively for breastfed babies to support mothers in their breastfeeding journey. Calma is a research-based nipple used with a BPA-free breastmilk bottle designed to help babies to maintain their natural feeding behavior and transition from bottle back to breast with ease — a revolution for breastfeeding mothers.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53588-medela-announces-u-s-launch-of-calma-for-breastfeeding
